IO Biotech, Inc.
IOBT
$1.30
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.44% | -30.47% | -16.09% | -6.32% | 25.69% |
| Total Depreciation and Amortization | 3.65% | 6.83% | -4.21% | 1.42% | 4.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.43% | 12,017.31% | -97.00% | -14.59% | 75.98% |
| Change in Net Operating Assets | -149.17% | 75.86% | 67.90% | 122.77% | -479.49% |
| Cash from Operations | -17.56% | 5.69% | -22.53% | 31.89% | -9.37% |
| Capital Expenditure | -154.55% | -10.00% | 16.67% | -9.09% | 90.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -154.55% | -10.00% | 16.67% | -9.09% | 90.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 129.73% | -302.34% | 206.22% | 10.07% | -144.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.85% | 1.98% | -19.30% | 31.64% | -13.01% |